Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2005
06/15/2005EP1539939A1 Method for the production of virus-analog particles for packing biologically active macromolecule by in vitro assembly of capsomers to which the macromolecules are bound
06/15/2005EP1539938A1 Chimeric gb virus b (gbv-b)
06/15/2005EP1539937A2 Methods for propagating adenovirus and virus produced thereby
06/15/2005EP1539820A2 Ostertagia vaccine
06/15/2005EP1539815A1 Crystal structure of an angiotensin-converting enzyme (ace) and uses thereof
06/15/2005EP1539814A2 Full-length interferon gamma polypeptide variants
06/15/2005EP1539813A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
06/15/2005EP1539812A2 Osteoinductive biomaterials
06/15/2005EP1539810A1 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
06/15/2005EP1539809A2 Hcv fusion proteins with modified ns3 domains
06/15/2005EP1539808A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
06/15/2005EP1539807A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
06/15/2005EP1539806A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use
06/15/2005EP1539805A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
06/15/2005EP1539802A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
06/15/2005EP1539801A2 Synthetic heparin-binding growth factor analogs
06/15/2005EP1539798A1 Process for protein extraction
06/15/2005EP1539797A1 Process for manufacturing crystals of growth hormone
06/15/2005EP1539794A2 Benzoate- and anthranilate-inducible promoters
06/15/2005EP1539792A2 Cngh0005 polypeptides, antibodies, compositions, methods and uses
06/15/2005EP1539789A2 Promoter sequences for urocortin ii the use thereof
06/15/2005EP1539786A2 Humanized renilla reniformis green fluorescent protein as a scaffold
06/15/2005EP1539785A2 Gene regulation in transgenic animals using a transposon-based vector
06/15/2005EP1539247A2 Alpha 5 beta 1 and its ability to regulate the cell survival pathway
06/15/2005EP1539228A2 Novel composition and methods for the treatment of immune related diseases
06/15/2005EP1539221A2 Transferrin fusion protein libraries
06/15/2005EP1539219A2 Affinity small molecules for the epo receptor
06/15/2005EP1539218A2 Compositions and methods for modulating lymphocyte activity
06/15/2005EP1539216A2 Labelled somatostatin analogs backbone cyclized through metal complexation
06/15/2005EP1539215A2 Adjuvant-free peptide vaccine
06/15/2005EP1539210A2 Modified glp-1 receptor agonists and their pharmacological methods of use
06/15/2005EP1539208A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
06/15/2005EP1539207A1 Treatment of cell proliferative disorders with chlorotoxin
06/15/2005EP1539198A2 Lentiviral vector-mediated gene transfer and uses thereof
06/15/2005EP1538907A2 Inhibitors of ftsz and uses thereof
06/15/2005EP1538900A2 Cancer vaccines containing epitopes of oncofetal antigen
06/15/2005EP1485129A4 Nanostructures containing pilin protein
06/15/2005EP1435975A4 Methods of using 279, a human g protein-coupled receptor
06/15/2005EP1383924A4 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
06/15/2005EP1381303A4 Transmission assembly for a surgical biopsy device
06/15/2005EP1373576A4 Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates
06/15/2005EP1309625B1 Therapeutic compounds for ovarian cancer
06/15/2005EP1275000A4 Detection of erythropoietin and erythtropoietin receptor
06/15/2005EP1218410B1 Process for obtaining growth factor preparations (tgf-beta and igf-1) from milk products having low mutual cross-contamination
06/15/2005EP1212420B1 Conditional immortalisation of cells
06/15/2005EP1180160B1 Antibiotic-based gene regulation system
06/15/2005EP1163340B1 Compositions and methods for the modification of gene expression
06/15/2005EP1075270B1 Short peptide for treatment of neurological degenerative diseases
06/15/2005EP1066050B1 Application of hsp70 proteins
06/15/2005EP1012338B1 A tumor suppressor designated ts10q23.3
06/15/2005EP1005537A4 Nucleic acid molecules specific for bacterial antigens and uses thereof
06/15/2005EP1005359B1 FRACTURE HEALING USING PTHrP ANALOGS
06/15/2005EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
06/15/2005EP0977587B1 Chimeric flavivirus vaccines
06/15/2005EP0954602B1 Hereditary hemochromatosis gene
06/15/2005EP0914344B1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP
06/15/2005EP0885241B1 Purification method
06/15/2005EP0837940B1 Ftsy expressing gram-positive microorganisms with enhanced secretion properties
06/15/2005EP0753061B1 Oral vaccine compositions against infections with yersinia pestis
06/15/2005CN1628249A Paramycobacterial diagnostics and vaccines
06/15/2005CN1628179A Gene and protein relating to hepatocellular carcinoma
06/15/2005CN1628172A Novel meloidogyne-resistance gene and utilization thereof
06/15/2005CN1628170A Environmental stress-responsive promoters and genes encoding transcriptional factor
06/15/2005CN1628129A Stabilization of protein preparations
06/15/2005CN1628128A Mammal prolactin variants
06/15/2005CN1628127A Genes from drought stress tolerant tea plant and method of introducing water-stress tolerance
06/15/2005CN1628126A Modified transferrin fusion proteins
06/15/2005CN1626662A Genes for the synthesis of antipathogenic substances
06/15/2005CN1626661A Phytohemagglutinin and application
06/15/2005CN1626566A Process for the removal of porogens from temperature sensitive macroreticular polymers using steam at reduced pressure
06/15/2005CN1626552A Angiogenesis related molecules
06/15/2005CN1626551A Method for purifying composite interferon
06/15/2005CN1626550A Excreted proteins as indicators related to tumor and application
06/15/2005CN1626241A Proteins derived from white spot syndrome virus and uses thereof
06/15/2005CN1626238A Composition of multiple scattered mixture contg.polypeptide and its pharm compsn.
06/15/2005CN1626237A Antibiosis usage of a family of protein
06/15/2005CN1626062A Silk soap bar and processes for manufacture the same
06/15/2005CN1206360C Hybrid seed production
06/15/2005CN1206355C HIV vaccine
06/15/2005CN1206352C Usage of xylanase for prepn. of foods
06/15/2005CN1206342C Corgnebaclerium for producing L-lysine and method for preparing L-lysine
06/15/2005CN1206243C Yolk antibody and antigen of pig's infective enterogastritis virus and its preparing process
06/15/2005CN1206242C Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide
06/15/2005CN1206241C Novel natural antibacterial peptide, its code sequence and application
06/15/2005CN1206240C High efficiency ionic exchange membrane chromatography decontamination vitelloenin technology
06/15/2005CN1205995C Hybrid polypeptides with enhanced pharmacokinetic properties
06/14/2005US6906245 Introducing nucleotide sequence encoding variant of proto-porphyrinogen IX oxidase lacking FAD binding sequence; expressing and regenerating
06/14/2005US6906244 Using the polycomb proteins fertilization independent endosperm (FIE) and medea (MEA) for controlling activities of non-endosperm tissues such as floral meristem
06/14/2005US6906194 Fluorescence assay for kinase activity
06/14/2005US6906183 Process for the separation of glycosylated and nonglycosylated proteins
06/14/2005US6906181 Antibody; for use in the detection and modulation of stress and aging defects
06/14/2005US6906179 Antibody to SNIP1
06/14/2005US6906178 Nucleotide sequences coding polypeptide for use in the treatment of pain syndromes and insensitivity, inflammation, ischemia, and immunological defects
06/14/2005US6906177 Screening; psychological disorders, brain disorders, antiepileptic agents; genetic engineering
06/14/2005US6906176 Polypeptide or use in the fibrinolysis, digestion and coagulation
06/14/2005US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor.
06/14/2005US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
06/14/2005US6906173 Expression vector coding transport protein for use in the diagnosis and treatment of cell proliferative, nervous system, diabetic and vision defects
06/14/2005US6906172 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
06/14/2005US6906171 Process for the deprotection of protected thiols
1 ... 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 ... 2916